Cypherpunk Reports Full Year 2025 Financial Results

Core Insights - 2025 was a transformational year for Cypherpunk Technologies, marked by a $58.88 million private placement and a rebranding to focus on privacy technology and digital asset treasury strategy centered on Zcash [2][4]. Financial Highlights - The company reported a net income of $4.8 million for the year ended December 31, 2025, a significant turnaround from a net loss of $67.8 million in 2024, primarily due to $50.4 million in unrealized gains on ZEC treasury holdings [8][20]. - Research and development expenses decreased to $25.7 million in 2025 from $57.2 million in 2024, attributed to reduced clinical trial and manufacturing costs [9]. - General and administrative expenses were $10.9 million in 2025, down from $12.8 million in 2024, mainly due to decreased payroll and related expenses [10]. - Cash and cash equivalents totaled $14.0 million as of December 31, 2025, with ZEC treasury holdings valued at $147.4 million [11][21]. Strategic Developments - The company acquired 294,743.10 ZEC for its treasury and made a $5 million strategic investment in Zcash Open Development Lab (ZODL), enhancing its position in the Zcash ecosystem [3][5]. - Key appointments included industry leaders as board members and strategic advisors, such as Arjun Khemani and Zooko Wilcox, to strengthen the company's expertise in the digital asset space [6]. Subsidiary Progress - Leap Therapeutics, a subsidiary, presented final clinical data from the DeFianCe study for sirexatamab in colorectal cancer patients, indicating promising results in specific patient groups [7][13]. - The company is working on advancing a DKK1 biomarker diagnostic test and engaging with regulatory authorities for the registrational pathway of sirexatamab [7].